TrialClinical pharmacology in drug development2018

Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions.

Helen S Pentikis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.